Pay in 4 interest-free payments of $5.66 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Traffic 15 , 13051329 (2014)
it addresses the full spectrum of metabolic dysfunction, from blood sugar imbalance to fatty liver disease and systemic inflammation
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Funding This work was supported by the National Institutes of Health (NIH) (grant no
It is beneficial to pair it with Vitamin C or Niacinamide
US$ 26.73
US$ 23.29
US$ 22.03
US$ 22.06
US$ 25.13
